• Privacy Policy
  • Terms and Conditions

© 2026 Sciad

  • Our Expertise
    • Design
      • Ads & Social Graphics
      • Branding
      • Marketing Assets
      • Video & Animation
      • Website Design & Development
    • Digital Marketing
      • Conversion Rate Optimisation
      • Digital Analytics & Reporting
      • Digital Marketing Strategy
      • Digital Press Office
      • Email Marketing
      • Lead Generation
      • PPC Marketing
      • SEO Services
      • Social Media Marketing
    • PR & Communications
      • Brand Positioning & Key Messaging
      • Communications Strategy
      • Conferences & Event Support
      • Media Relations
      • Reputation Management
      • Thought Leadership
  • Sectors
    • Digital Health
    • Engineering
    • Healthcare, Diagnostics & Medical Devices
    • Laboratory Instruments & Suppliers
    • Life Science & Biotech
    • Pharmaceuticals & Medicine
    • Science
    • Science & Healthcare Charities
    • Science Publishing & Academic Collaboration
    • Synthetic Biology
    • Med Tech
  • Our Work
  • News
  • About Us
    • Our Team
    • Careers
  • Contact Us
  • Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic

    Queen’s University Belfast and Domainex Ltd secure funding from the Wellcome Trust to accelerate early development of first-in-class FLIP inhibitors.

    April 26, 2016
  • Synpromics Further Strengthens Board and Management Team

    Synpromics appoints Dr John Shields as Investor Director and Dr Ken Macnamara as Director of Operations.

    April 19, 2016
  • Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia

    Johnson Matthey and Domainex have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services.

    April 19, 2016
  • The RSA Group to Open New US HQ in Kendall Sq, Boston and Extend Facilities in London

    The RSA Group, the world’s largest Talent Consultancy in Life Science, is extending its US operation with a new office in Kendall Square, at the heart of the largest biotech cluster in the USA.

    April 11, 2016
  • Dow AgroSciences and TeselaGen Advance Biodesign Technologies for Agriculture

    Dow AgroSciences and TeselaGen announce collaboration to produce biological design automation platform.

    April 6, 2016
  • Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilites

    Twist Biosciences announces acquisition of Genome Compiler Corporation.

    April 6, 2016
  • UK’s First Commercial Synthetic Biology Foundry Goes Into Production

    New facility for engineering biology enables DNA synthesis, assembly and verification.

    April 6, 2016
  • Bento Lab – The DNA Laboratory for Everybody – Concludes Beta Testing

    London, UK, 23rd March 2016 / Sciad Newswire / Bento Lab, the first affordable DNA laboratory, has successfully concluded its beta-testing and is now preparing to fund its first production run. As well as seeking funding from traditional sources, Bento Lab is launching a Kickstarter campaign to fund the production run – giving people the chance to conduct experiments at home or in…

    March 23, 2016
  • Cypralis Limited Announces Appointment of Dr Michael Peel as Chief Scientific Officer

    Cypralis appoints Dr Michael Peel as Chief Scientific Officer.

    March 2, 2016
  • UK Strategic Plan for Synthetic Biology 2016 Released

    Minister for Life Sciences George Freeman MP will today visit SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.

    February 24, 2016
←Previous Page
1 … 63 64 65 66 67 … 80
Next Page→

We have all the tools to bring your innovation to life.

    • LinkedIn
    • X
Our Expertise
  • Design
  • Digital Marketing
  • PR & Communications
About Us
  • About Sciad
  • Our Team
  • Careers
Contact Us

hello@sciad.com

+44 (0)20 3405 7892

  • Privacy Policy
  • Terms & Conditions

© 2026 Sciad Communications